Using ABCG2-molecule-expressing side population cells to identify cancer stem-like cells in a human ovarian cell line

Cell Biology International

Volumn 35, Issue 3, 2011, Pages 227-234

  Dou, Jun ^a   Jiang, Cuilian ^b   Wang, Jing ^c   Zhang, Xian ^c   Zhao, Fengshu ^a   Hu, Weihua ^a   He, Xiangfeng ^a   Li, Xiaoli ^a   Zou, Dandan ^a   Gu, Ning ^c  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

^b Maternal and Child Health   (China)

^c SOUTHEAST UNIVERSITY   (China)

Author keywords

ABCG2 molecule; Cancer stem cell; Cancer stem like cell; Ovarian cancer; Side population cell

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; VINBLASTINE;

AGAR MEDIUM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLOGICAL ACTIVITY; CANCER CELL; CANCER RESISTANCE; CANCER STEM CELL; CANCER STEM LIKE CELL; CARCINOGENESIS; CELL ACTIVITY; CELL FRACTIONATION; CELL PROLIFERATION; CELL RENEWAL; CELL SELECTION; CELL SUBPOPULATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; MOUSE; NONHUMAN; OVARY CANCER; PROTEIN EXPRESSION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SEPARATION; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM PROTEINS; NEOPLASTIC STEM CELLS; OVARIAN NEOPLASMS; SIDE-POPULATION CELLS; VINCRISTINE;

MUS MUSCULUS;

EID: 79957626880     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1042/CBI20100347     Document Type: Article

References (33)

1. Al-Hajj M, Clarke MF. Self-renewal and solid tumor stem cells. Oncogene 2004;23:7274-82.
2. Baba T, Convery PA, Matsumura N, Whitaker RS, Kondon E, Perry T, Huang Z, Bentley RC, Mori S, Fujii S, Marks JR, Berchuck A, Murphy SK. Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells. Oncogene 2009;28:209-18.
3. Burkert J, Otto WR and Wright NA. Side populations of gastrointestinal cancers are not enriched in stem cells. J Pathol 2008;214:564-73.
4. Burkert J, Wright NA, Alison MR. Stem cells and cancer: an intimate relationship. J Pathol 2006;209:287-97.
5. Cuilian J. Primarily identification of ovarial cancer stem cells in a human ovarian cell line based on sorting side population cells. A Dissertation of the Academic Degree in Southeast University, China 2009;26-30.
6. Ferrandina G, Martinelli E, Petrillo M, Prisco MG, Zannoni G, Sioletic S, Scambia G. CD133 antigen expression in ovarian cancer. BMC Cancer 2009;9:221-9.
7. Galli R, Binda E, Orfanelli U. Isolation and characterization of tumorigenic stem-like neural precursors from human glioblastoma. Cancer Res 2004;64:7011-21.
8. Hakkarainen T, Hemminki A, Pereboev AV, Barker SD, Asiedu CK, Strong TV, Kanerva A, Wahlfors J, Curiel DT. CD40 is expressed on ovarian cancer cells and can be utilized for targeting adenoviruses. Clin Cancer Res 2003;9:619-24.
9. Henriksen U, Gether U, Litman T. Effect of Walker A mutation (K86M) on oligomerization and surface targeting of the multidrug resistance transporter ABCG2. J Cell Sci 2005;118:1417-24.
10. Hu L, McArthur C, Jaffe RB. Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant. Br J Cancer 2010;102:1276-83.
11. Ignatova TN, Kukekov VG, Laywell ED, Suslov ON, Vrionis FD, Steindler DA. Glial tumors contain neural stem like cells expressing astroglial and neuronal markers in vitro. Glia 2002;39:193-206.
12. Jun D, Meng P, Ping W, Li Y, Tang Q, Chu L, Zhao F, Jiang C, Hu W, Hu K, Gu N. Isolation and identification of cancer stem like cells from murine melanoma cell lines. Cell Mol Immunol 2007;4:528-33.
13. Jun D, Pengbo L, Jing W, Zhang X. Effect of hepatitis C virus core shadow protein expressed in human hepatoma cell line on human gene expression profiles. J Gastroenterol Hepatol 2006;21:1794-800.
14. Jun D, PingW,Weihua H, Li Y,Wu Y, Liu C, Zhao F, Hu K,Wang J, Jiang C, He X,Gu N. Identification of tumor stem-like cells inmouse melanoma cell line by analysis characteristics of side population cells. Cell Biol Int 2009a;33:807-15.
15. Jun D, Yating L,Weihua H, Hu W, Wen P, Tang Q, Chu L, Wang Y, Cao M, Jiang C, Gu N. Identification of tumor stem like cells in mouse myeloma cell lines. Cell Mol Biol (Noisy-le-grand) 2009b;55Suppl:OL1151-60.
16. Kim CF, Jackson E L, Woolfenden AE. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 2005;121:823-35.
17. Kim M, Turnquist H, Jackson J. The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells. Clin Cancer Res 2002;8:22-8.
18. Kusumbe AP, Mali AM, Bapat SA. CD133-expressing stem cells associated with varian metastases establish an endothelial hierarchy and contribute to tumor vasculature. Stem Cells 2009;27:498-508.
19. Lubna P, Tammy C, Robin SB, Zhou J, Claypool K, Tang DG. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG22 cancer cells are similarly tumorigenic. Cancer Res 2005;65:6207-19.
20. Maranon C, Planelles L, Alonso C. HSP70 from Trypanosoma cruzi is endowed with specific cell proliferation potential leading to apoptosis. Int Immunol 2000;12:1685-93.
21. Matsui W, Huff CA, Wang Q. Characterization of clonogenic multiple myeloma cells. Blood 2004;103:2332-6.
22. Michael D, Tito F and Susan B. Tumor stem cells and drug resistance. Nature Rev 2005;5:275-84.
23. Moserle L, Indraccolo S, Ghisi M, Frasson C, Fortunato E, Canevari S, Miotti S, Tosello V,Zamarchi R, Corradin A, Minuzzo S, Rossi E, Basso G, Amadori A. The side population of ovarian cancer cells is a primary target of IFN-alpha antitumor effects. Cancer Res 2008;68:5658-68.
24. Mosmann T R. Colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
25. Müller-Tidow C, Metzger R, Kügler K, Diederichs S, Idos G, Thomas M, Dockhorn-Dworniczak B, Schneider PM, Koeffler HP, Berdel WE, Serve H. Cyclin E is the only cyclin-dependent kinase 2-associated cyclin that predicts metastasis and survival in early stage non-small cell lung cancer.Cancer Res 2001;61:647-53.
26. Neethan A L, Yohei S, Dalong Q, Clarke MF. The biology of cancer stem cells. Annu Rev Cell Dev Biol 2007;23:675-99.
27. Ouyang L, Shen LY, Li T, Liu J. Inhibition effect of oncostatin M on metastatic human lung cancer cells 95D in vitro and on murine melanoma cells B16BL6 in vivo. Biomed Res 2006;27:197-202.
28. Pan Y, Huang X. Epithelial ovarian cancer stem cells-a review. Int J Clin Exp Med 2008;1:260-6.
29. Perillo A, Bonanno G, Pierelli L, Rutella S, Scambia G, Mancuso S. Stem cells in gynecology and obstetrics. Panminerva Med 2004;46:49-59.
30. Santin AD. Prospective identification and characterization of ovarian cancer stem cells: implications for the treatment of chemotherapy resistant/recurrent ovarian disease. Cell Cycle 2009;8:3-5.
31. Wang J, Guo LP, Chen LZ, Zeng YX, Lu SH. Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line. Cancer Res 2007;67:3716-24.
32. Zhang S, Balch C, Chan MW, Lai HC, Matei D, Schilder JM, Yan PS, Huang TH, Nephew KP. Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res 2008;68:4311-320.
33. Zou GM. Cancer initiating cells or cancer stem cells in the gastrointestinal tract and liver. J Cell Physiol 2008;217:598-604.